AI 导读
OpenAI 宣布收购 Orchestra Bio，该平台帮助生物制药团队协调复杂的药物开发流程。双方将在生命科学研究模型与工具 Rosalind 基础上整合，以简化研发运营、加快新疗法触达患者。
正文
OpenAI ❤️ Orchestra Bio
> OpenAI has acquired Orchestra Bio to work on Rosalind models and tools for life sciences research.
> "Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."
AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：🚨 AI News | TestingCatalog · x.com